marijuana stocks

GW Pharmaceuticals Poised For New All-Time High Close On Appropriate Day

Joel Elconin is the co-host of Benzinga’s #PreMarket Prep, a daily trading idea radio show.

GW Pharmaceuticals (NASDAQ: GWPH) shares were up about $0.31 at $114.31 in Monday’s session. The issue, one of the only bright spots in the marijuana sector this year, is attempting to post an all-time closing high on a very appropriate day, April 20, better known as 4/20 in marijuana culture.

The issue, which leaped in one week from its April 9 close ($90.84) to $114 on April 16, on the heels of positive data regarding its blockbuster drug Epidiolex for the treatment of Epilepsy, has found a group of willing sellers in the $116 handle.

Related Link: Marijuana Stocks Not Very High On 4/20

After peaking on Friday at $116.42, it found sellers ahead of that level in Monday’s session at $116.14, before falling back under its all-time high close of $114.

So far, GW Pharmaceuticals has far outperformed the broad market for 2015, rallying from its December 31 close ($67.68) or 68 percent (based on $114), compared with the broad market’s return of 2 percent.

See more from Benzinga


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Neptune Wellness Solutions Inc. (NEPT) Fiscal Second Quarter 2022 Financial Results on November 15, 2021

Neptune to Report Fiscal Second Quarter 2022 Financial Results on November 15,…

Emblem Corp. (EMMBF) Announces 2017 Financial Results

Emblem Announces 2017 Financial Results NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE…

Innovative Industrial Properties, Inc. (IIPR) Expands Real Estate Partnership with AWH at Illinois Property

Innovative Industrial Properties Expands Real Estate Partnership with AWH at Illinois Property…

Medical Marijuana, Inc. (MJNA) Provides Update on its Pharmaceutical Initiatives

Medical Marijuana, Inc. Provides Update on its Pharmaceutical Initiatives Medical Marijuana, Inc.…